What You Should Know
Craif Inc., a bio-AI company developing a non-invasive urine analysis platform for early cancer detection, closed an approximately $33M Series D round (¥5.28 billion), bringing its total capital raised to roughly $88M (¥14.2 billion).The financing was co-led by
Read More
Craif Secures $33M to Bring AI-Powered Urine Oncology Diagnostics to the U.S.






























































